| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |